Bone Biologics Corp | Needs refresh | Last updated: 2026-06-01T17:55:29Z
Bone Biologics Corp is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for Abatacept in Rheumatoid Arthritis (RA) (Phase 3) using Vaccine.
| Asset | Indication | Modality | Stage | Public Note |
|---|---|---|---|---|
| Herpes Zoster (HZ) Vaccine | n/a | Vaccine | Phase 2 | Public pipeline row |
| Guselkumab | Arthritis, Psoriatic | n/a | Phase 2 | Public pipeline row |
| Osteogenic markers Evaluation | Jaw, Edentulous | n/a | Na | Public pipeline row |
| 7 mm Diameter Dental Implant | Partial Edentulism in the Maxilla or in the Mandible | Immediate Implant Placement | n/a | Na | Public pipeline row |
| Abatacept | Rheumatoid Arthritis (RA) | n/a | Phase 3 | Public pipeline row |
No public catalyst rows matched this view yet.
Estimated cash runway: Runway > 12 months.
This is an automated estimate and may differ from company guidance.
| NCT ID | Phase | Status | Enrollment | Primary Completion |
|---|---|---|---|---|
| NCT01909999 | Na | COMPLETED | 40 | 2012-10 |
| NCT03086343 | Phase 3 | COMPLETED | 657 | 2019-06-13 |
| NCT02538341 | Phase 2 | COMPLETED | 617 | 2019-12 |
| NCT05071664 | Phase 2 | COMPLETED | 91 | 2024-05-14 |
| NCT07041294 | Na | ACTIVE_NOT_RECRUITING | 70 | 2025-05-15 |
Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.
Get the weekly biotech catalyst watchlistThis page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.